Tanner Pharma Group
For over two decades, Tanner Pharma Group has partnered with governments, regulators, healthcare providers, and biopharma innovators to deliver life-saving treatments to patients—no matter the geography, infrastructure, or market size. As specialists in Managed Access Programs, we enable ethical, compliant access to medicines in markets where they are not yet commercially available. We assume full responsibility for ensuring a structured, uninterrupted supply of innovative therapies, while providing tailored regulatory strategies, expert program management, and real-world evidence support. With strategic operations in the U.S., U.K., Switzerland, and Ireland, our global network and agile approach empower us to overcome access barriers and deliver even the most complex initiatives seamlessly.
